Pulse8 extends the Utility and Technology of its powerful analytic engine, Illumin8 Active Intelligence™ platform
March 18 2019 - 8:01AM
Pulse8, part of Veradigm™, an Allscripts (NASDAQ: MDRX) business
unit, the first – and ONLY one with a patent pending – healthcare
analytics and technology company delivering complete visibility
into the efficacy of Risk Adjustment, Quality Management, and
Pharmacy Benefit Management programs, proudly debuted several
significant enhancements to its illumin8 Solution Suite this
quarter – most notably, the advent of an
ACO-specific
module to their flagship risk adjustment solution as well
as the implementation of
Pulse Alerts across its
customer base of innovative health plans and at-risk providers.
Pulse Alerts are yet another embodiment of the
advanced illumin8 Active Intelligence platform that Pulse8
announced at last year’s RISE Nashville Summit. Now
implemented at various health plans across the country, Pulse
Alerts radically transform data analysis from a reactive and
laborious data mining exercise to a proactive and insightful
process.
“Why wait and wonder what has changed? Why
insist on continuously checking to see how you’re tracking against
benchmarks?” said Scott Stratton, MPH, Chief Data Scientist and
Vice President of Product Analytics at Pulse8. “Our new Pulse
Alerts feature will notify you when key metrics are in jeopardy and
if action is warranted. All you have to do is simply set the
parameters on your Key Performance Indicators and the system will
alert you whenever one of those metrics is off kilter – or monitor
your KPIs through your own personalized Pulse Page.”
Pulse8 is also extending its analytic support of
risk relationships for and with provider groups that have
established an Accountable Care Organization (ACO) through its risk
adjustment analytics solution, Calcul8™, and its provider
engagement platform, Collabor8™. Whether taking on risk as an
ACO or delegating risk to an affiliated medical group, this
expanded functionality will provide greater visibility into risk
scores, benchmark adherence, and provider performance.
“Our new ACO-specific module monitors one’s
progress to shared savings caps and risk score-based payments –
while calculating how best to reach the goal line,” said Eric
Hedrick, Director of ACO Products at Pulse8. “We calculate
the value of closing each gap and identify the members and
providers with whom to engage. Our new module assesses cost
drivers and monitors provider performance, so you can minimize
network leakage and optimally deploy educational resources.”
“Pulse8 is continually enhancing our solutions
and augmenting our value proposition,” explained Pulse8 CEO, John
Criswell. “Another exciting development has been the marriage
of Quality and Risk Adjustment Gaps within our Collabor8
platform. In tandem with our patent-pending Dynamic
Intervention Planning, our customers now benefit from a level of
coordination when pursuing open gaps in documentation, coding, and
quality that minimizes administrative waste and provider abrasion –
and optimizes return on investment.”
Pulse8 will be a Platinum Sponsor at this week’s
13th-Annual RISE Nashville Summit. Visit Pulse8 in Booth #3
to talk with subject matter experts about these exciting new
developments or schedule a demo by contacting Scott Filiault,
Pulse8 Chief Revenue Officer, at (732) 570-9095 or
Scott.Filiault@Pulse8.com.
About Pulse8Pulse8 is a
Healthcare Analytics and Technology Company delivering complete
visibility into the efficacy of your Risk Adjustment, Quality, and
Pharmacy Benefit Management programs. We enable health plans and
providers to eliminate waste and achieve the greatest financial
impact in the Medicare Advantage, Medicaid, and ACA Commercial
markets as well as with Value-Based Payment models for Medicare.
Our advanced analytic methodologies and flexible business
intelligence tools offer real-time visibility into member behavior
and provider performance. Pulse8’s Illumin8 Active Intelligence™
platform offers a suite of uniquely pragmatic solutions that are
powered by our patent-pending Dynamic Intervention Planning to
deliver the most cost-effective and appropriate interventions for
closing gaps in documentation, coding, and quality. For more
company information or to schedule a demo, please contact Scott
Filiault at (732) 570-9095 or scott.filiault@pulse8.com.
About Veradigm Veradigm is an
integrated data systems and services business that combines
data-driven clinical insights with actionable tools for clinical
workflow, research, analytics, and media. Our solutions are
designed to help key healthcare stakeholders to improve the
quality, efficiency, and value of healthcare delivery - from
biopharma to health plans, healthcare providers, health technology
partners, and most importantly, the patients they serve. We are
dedicated to simplifying the complicated healthcare system with
next-generation healthcare solutions. That is how we are
transforming health, insightfully. To learn more, visit
www.veradigmhealth.com, Twitter, Facebook, and LinkedIn.
About Allscripts Allscripts
(NASDAQ: MDRX) is a leader in healthcare information technology
solutions that advance clinical, financial and operational results.
Our innovative solutions connect people, places and data across an
Open, Connected Community of Health™. Connectivity empowers
caregivers and consumers to make better decisions, delivering
better care for healthier populations. To learn more, visit
www.allscripts.com, Twitter,
YouTube and It Takes A Community: The
Allscripts Blog.
© 2019 Allscripts Healthcare, LLC and/or its
affiliates. All Rights Reserved.
Allscripts, the Allscripts logo, and other
Allscripts marks are trademarks of Allscripts Healthcare, LLC
and/or its affiliates. All other products are trademarks of their
respective holders, all rights reserved. Reference to these
products is not intended to imply affiliation with or sponsorship
of Allscripts Healthcare, LLC and/or its affiliates.
For more information
contact:
Investors:
Stephen Shulstein 312-386-6735
Stephen.Shulstein@allscripts.com
Media:
Concetta Rasiarmos 312-447-2466
concetta.rasiarmos@allscripts.com
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Sep 2023 to Sep 2024